Structural and immunogenic characteristics of rabies immunosomes
- PMID: 4043539
Structural and immunogenic characteristics of rabies immunosomes
Abstract
Rabies immunosomes are prepared by the anchorage of glycoprotein molecules to preformed liposomes. Virosomes are associations of glycoprotein molecules with viral or non viral lipids. Virosomes can be obtained spontaneously after removal of the detergent used for lipids solubilization. Under the electron microscope immunosomes look like homogenous spherical vesicles (50-60 nm) evenly covered with spikes, although glycoprotein molecule orientation in virosomes is not yet clearly established. In addition, the size of virosomes is very heterogeneous. When glycoprotein molecules are in immunosome form, their accessibility to a lectin (WGA) is identical to that of the purified virus. Under the same conditions with virosomes accessibility is weaker. Protection induced in mice is ten to twenty fold higher with rabies immunosomes than with purified glycoprotein or virosomes. The results presented here and previous reports (10) show that immunosomes have structural and immunogen characteristics closer to those of purified and inactivated virus than does any other form of glycoprotein lipids association.
Similar articles
-
Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies.Vaccine. 1985 Sep;3(3):325-32. doi: 10.1016/s0264-410x(85)90224-5. Vaccine. 1985. PMID: 4060842
-
The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2.Cell Immunol. 1987 Aug;108(1):220-6. doi: 10.1016/0008-8749(87)90206-1. Cell Immunol. 1987. PMID: 3496973
-
Interleukin-2 production in vitro: a new approach to the study of rabies vaccine immunogenicity as appraised by testing different glycoprotein presentations.Vaccine. 1988 Aug;6(4):331-8. doi: 10.1016/0264-410x(88)90179-x. Vaccine. 1988. PMID: 2461004
-
The use of immunosome technology for vaccines against rabies and other viral diseases.Eur J Epidemiol. 1989 Sep;5(3):275-8. doi: 10.1007/BF00144826. Eur J Epidemiol. 1989. PMID: 2477273 Review.
-
Canine adenovirus based rabies vaccines.Dev Biol (Basel). 2008;131:467-76. Dev Biol (Basel). 2008. PMID: 18634509 Review.
Cited by
-
Direct stimulation of T lymphocytes by immunosomes: virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules.Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13144-9. doi: 10.1073/pnas.0602283103. Epub 2006 Aug 21. Proc Natl Acad Sci U S A. 2006. PMID: 16924110 Free PMC article.
-
Extending gene ontology in the context of extracellular RNA and vesicle communication.J Biomed Semantics. 2016 Apr 12;7:19. doi: 10.1186/s13326-016-0061-5. eCollection 2016. J Biomed Semantics. 2016. PMID: 27076901 Free PMC article.
-
Liposome technology for industrial purposes.J Drug Deliv. 2011;2011:591325. doi: 10.1155/2011/591325. Epub 2010 Dec 5. J Drug Deliv. 2011. PMID: 21490754 Free PMC article.
-
Enzyme-linked immunosorbent assay for determination of antibodies to the envelope glycoprotein of rabies virus.J Clin Microbiol. 1989 May;27(5):899-902. doi: 10.1128/jcm.27.5.899-902.1989. J Clin Microbiol. 1989. PMID: 2745698 Free PMC article.
-
Delivery strategies for novel vaccine formulations.World J Virol. 2012 Feb 12;1(1):4-10. doi: 10.5501/wjv.v1.i1.4. World J Virol. 2012. PMID: 24175206 Free PMC article.